In-Depth: Is AstraZeneca's Evusheld a turning point against COVID?

Cancer patients and others with compromised immune systems have high hopes for a newly authorized drug from AstraZeneca, the first medicine designed to prevent COVID in people who mount weak responses to vaccines.